Chemo-immunotherapy was successfully implemented in melanoma bearing mice using a PVP microneedle patch loaded with lipid coated cisplatin, an antineoplastic agent and anti-PD1 antibodies for immunotherapy. The gene discussed is PDCD1; the disease is melanoma.